Investigation of Cardiovascular Effects of Tetrahydro-β-carboline sstr3 antagonists
-
Published:2014-04-28
Issue:7
Volume:5
Page:748-753
-
ISSN:1948-5875
-
Container-title:ACS Medicinal Chemistry Letters
-
language:en
-
Short-container-title:ACS Med. Chem. Lett.
Author:
He Shuwen, Lai Zhong, Ye Zhixiong, Dobbelaar Peter H., Shah Shrenik K., Truong Quang, Du Wu, Guo Liangqin, Liu Jian, Jian Tianying, Qi Hongbo, Bakshi Raman K., Hong Qingmei, Dellureficio James, Reibarkh Mikhail, Samuel Koppara, Reddy Vijay B., Mitelman Stan, Tong Sharon X., Chicchi Gary G., Tsao Kwei-Lan, Trusca Dorina, Wu Margaret, Shao Qing, Trujillo Maria E., Fernandez Guillermo1, Nelson Donald1, Bunting Patricia1, Kerr Janet1, Fitzgerald Patrick1, Morissette Pierre1, Volksdorf Sylvia1, Eiermann George J., Li Cai, Zhang Bei, Howard Andrew D., Zhou Yun-Ping, Nargund Ravi P., Hagmann William K.
Affiliation:
1. Department
of Safety Assessment, 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States
Publisher
American Chemical Society (ACS)
Subject
Organic Chemistry,Drug Discovery,Biochemistry
Reference25 articles.
1. Identification of Potent Non-Peptide Somatostatin Antagonists with sst3 Selectivity 2. Thurieau, C.; Poitout, L.; Galcera, M.; Moinet, C.; Gordon, T. D.; Morgan, B. A.; Bigg, D.; Pommier, J.β-Carboline Compounds. WO 1999/64420, December 16, 1999. 3. Troxler, T.; Hurth, K.; Hoyer, D.Beta-Carboline Derivatives and Its Pharmaceutical Use Against Depression and Anxiety. WO 2002/081471, April 2, 2002. 4. Decahydroisoquinoline derivatives as novel non-peptidic, potent and subtype-selective somatostatin sst3 receptor antagonists
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|